These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1165 related articles for article (PubMed ID: 24119319)

  • 1. Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies.
    Porst H; Gacci M; Büttner H; Henneges C; Boess F
    Eur Urol; 2014 Feb; 65(2):455-64. PubMed ID: 24119319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT).
    Montorsi F; Brock G; Stolzenburg JU; Mulhall J; Moncada I; Patel HR; Chevallier D; Krajka K; Henneges C; Dickson R; Büttner H
    Eur Urol; 2014 Mar; 65(3):587-96. PubMed ID: 24169081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale.
    Rosen RC; Allen KR; Ni X; Araujo AB
    Eur Urol; 2011 Nov; 60(5):1010-6. PubMed ID: 21855209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial.
    Porst H; Kim ED; Casabé AR; Mirone V; Secrest RJ; Xu L; Sundin DP; Viktrup L;
    Eur Urol; 2011 Nov; 60(5):1105-13. PubMed ID: 21871706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Porst H; Giuliano F; Glina S; Ralph D; Casabé AR; Elion-Mboussa A; Shen W; Whitaker JS
    Eur Urol; 2006 Aug; 50(2):351-9. PubMed ID: 16766116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled, parallel study to assess the efficacy and safety of once-a-day tadalafil in men with erectile dysfunction who are naïve to PDE5 inhibitors.
    Montorsi F; Aversa A; Moncada I; Perimenis P; Porst H; Barker C; Shane MA; Sorsaburu S
    J Sex Med; 2011 Sep; 8(9):2617-24. PubMed ID: 21707928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in South-East Asian men.
    Guo YL; Zhu JC; Pan TM; Ding Q; Wang YX; Cheong NF; Lim E; Shen W; Venugopalan M; Chan M
    Int J Urol; 2006 Jun; 13(6):721-7. PubMed ID: 16834650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of low testosterone on response to treatment with tadalafil 5 mg once daily for erectile dysfunction.
    Goldfischer ER; Kim ED; Seftel AD; Baygani SK; Burns PR
    Urology; 2014 Jun; 83(6):1326-33. PubMed ID: 24726311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of oral tadalafil in the treatment of men in Canada with erectile dysfunction: a randomized, double-blind, parallel, placebo-controlled clinical trial.
    Carrier S; Brock GB; Pommerville PJ; Shin J; Anglin G; Whitaker S; Beasley CM
    J Sex Med; 2005 Sep; 2(5):685-98. PubMed ID: 16422827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
    Eardley I; Gentile V; Austoni E; Hackett G; Lembo D; Wang C; Beardsworth A
    BJU Int; 2004 Oct; 94(6):871-7. PubMed ID: 15476525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of once-daily dosing of udenafil in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Zhao C; Kim SW; Yang DY; Kim JJ; Park NC; Lee SW; Paick JS; Ahn TY; Min KS; Park K; Park JK
    Eur Urol; 2011 Aug; 60(2):380-7. PubMed ID: 21458153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.
    Skoumal R; Chen J; Kula K; Breza J; Calomfirescu N; Basson BR; Kopernicky V
    Eur Urol; 2004 Sep; 46(3):362-9; discussion 369. PubMed ID: 15306109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of tadalafil in improving sexual satisfaction and overall satisfaction in men with mild, moderate, and severe erectile dysfunction: a retrospective pooled analysis of data from randomized, placebo-controlled clinical trials.
    Rosen RC; Shabsigh R; Kuritzky L; Wang WC; Sides GD
    Curr Med Res Opin; 2005 Nov; 21(11):1701-9. PubMed ID: 16307689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploratory Decision-Tree Modeling of Data from the Randomized REACTT Trial of Tadalafil Versus Placebo to Predict Recovery of Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy.
    Montorsi F; Oelke M; Henneges C; Brock G; Salonia A; d'Anzeo G; Rossi A; Mulhall JP; Büttner H
    Eur Urol; 2016 Sep; 70(3):529-37. PubMed ID: 26947602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of once-daily tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline.
    Shabsigh R; Seftel AD; Kim ED; Ni X; Burns PR
    J Sex Med; 2013 Mar; 10(3):844-56. PubMed ID: 23035781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 12 weeks of tadalafil treatment on ejaculatory and orgasmic dysfunction and sexual satisfaction in patients with mild to severe erectile dysfunction: integrated analysis of 17 placebo-controlled studies.
    Paduch DA; Bolyakov A; Polzer PK; Watts SD
    BJU Int; 2013 Feb; 111(2):334-43. PubMed ID: 23356749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Durability of response following cessation of tadalafil taken once daily as treatment for erectile dysfunction.
    Porst H; Glina S; Ralph D; Zeigler H; Wong DG; Woodward B
    J Sex Med; 2010 Oct; 7(10):3487-94. PubMed ID: 20584129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A return to normal erectile function with tadalafil once daily after an incomplete response to as-needed PDE5 inhibitor therapy.
    Kim ED; Seftel AD; Goldfischer ER; Ni X; Burns PR
    J Sex Med; 2014 Mar; 11(3):820-30. PubMed ID: 23841532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind study.
    Egerdie RB; Auerbach S; Roehrborn CG; Costa P; Garza MS; Esler AL; Wong DG; Secrest RJ
    J Sex Med; 2012 Jan; 9(1):271-81. PubMed ID: 21981682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of tadalafil in clinical populations.
    Lewis RW; Sadovsky R; Eardley I; O'Leary M; Seftel A; Wang WC; Shen W; Walker DJ; Wong DG; Ahuja S
    J Sex Med; 2005 Jul; 2(4):517-31. PubMed ID: 16422847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.